Heart hormones inhibit growth of pancreatic cancer cells in laboratory, USF/VA study finds

June 19, 2003

Tampa, FL (June 19, 2003) -- For the first time, hormones made by the heart have been shown to dramatically decrease the number of human pancreatic cancer cells grown in a laboratory, report researchers at the University of South Florida Cardiac Hormone Center and the James A. Haley Veterans' Hospital.

The four hormones were at least twice as effective at tumor cell reduction as 5-fluorouracil -- a standard drug used for 45 years to treat pancreatic cancer.

The findings will be presented June 20 in Philadelphia, PA, at ENDO 2003, the 85th Annual Meeting of The Endocrine Society.

"The results were surprising and striking," said USF endocrinologist David Vesely, MD, PhD, the study's principal investigator. "One of these peptide hormones, called vessel dilator, killed 65 percent of the pancreatic adenocarcinoma cells within 24 hours compared to the population of untreated cancer cells. Equally important, DNA synthesis seems to stay shut down -- the remaining cancer cells don't make new cells."

The researchers found that the hormones appear to work by inhibiting DNA synthesis and the growth of cancer cells, not by prompting cancer cells to self-destruct, a process known as apoptosis.

The researchers looked at the effects of four peptide hormones produced mainly by the heart to help lower blood pressure and promote excretion of excess salt and water. In addition to vessel dilator, they were long-acting natriuretic peptide (LANP), kaliuretic peptide and atrial natriuretic peptide (ANP). Three of the four hormones, all except ANP, were discovered by Dr. Vesely.

A small dose of LANP added to pancreatic cancer cells grown in a petri dish reduced the number of cells by 47 percent in 24 hours. The decrease in cancer cells was 37 percent for kaliuretic peptide and 34 percent for ANP. The decreases were sustained for the 4-day length of the experiment. In contrast, the chemotherapeutic drug 5-fluorouracil reduced pancreatic cells grown in culture by only 16 percent.

Dr. Vesely has studied for several years the use of hormones made by the heart, collectively known as atrial natriuretic peptides, to diagnose and treat congestive heart failure. This latest study suggests they may also hold promise for treating a variety of adenocarcinomas, including those in the breast, prostate and colon as well as the pancreas, he said. "One benefit of these naturally-occurring hormones is they have fewer side effects than other drugs."

The researchers are applying for funding to test the effectiveness of the four heart hormones in mice with human adenocarcinomas.
-end-


University of South Florida (USF Health)

Related Cancer Cells Articles from Brightsurf:

Cancer researchers train white blood cells to attacks tumor cells
Scientists at the National Center for Tumor Diseases Dresden (NCT/UCC) and Dresden University Medicine, together with an international team of researchers, were able to demonstrate that certain white blood cells, so-called neutrophil granulocytes, can potentially - after completing a special training program -- be utilized for the treatment of tumors.

New way to target some rapidly dividing cancer cells, leaving healthy cells unharmed
Scientists at Johns Hopkins Medicine and the University of Oxford say they have found a new way to kill some multiplying human breast cancer cells by selectively attacking the core of their cell division machinery.

Breast cancer cells use message-carrying vesicles to send oncogenic stimuli to normal cells
According to a Wistar study, breast cancer cells starved for oxygen send out messages that induce oncogenic changes in surrounding normal epithelial cells.

Breast cancer cells turn killer immune cells into allies
Researchers at Johns Hopkins University School of Medicine have discovered that breast cancer cells can alter the function of immune cells known as Natural killer (NK) cells so that instead of killing the cancer cells, they facilitate their spread to other parts of the body.

Breast cancer cells can reprogram immune cells to assist in metastasis
Johns Hopkins Kimmel Cancer Center investigators report they have uncovered a new mechanism by which invasive breast cancer cells evade the immune system to metastasize, or spread, to other areas of the body.

Engineered immune cells recognize, attack human and mouse solid-tumor cancer cells
CAR-T therapy has been used successfully in patients with blood cancers such as lymphoma and leukemia.

Drug that keeps surface receptors on cancer cells makes them more visible to immune cells
A drug that is already clinically available for the treatment of nausea and psychosis, called prochlorperazine (PCZ), inhibits the internalization of receptors on the surface of tumor cells, thereby increasing the ability of anticancer antibodies to bind to the receptors and mount more effective immune responses.

Engineered bone marrow cells slow growth of prostate and pancreatic cancer cells
In experiments with mice, researchers at the Johns Hopkins Kimmel Cancer Center say they have slowed the growth of transplanted human prostate and pancreatic cancer cells by introducing bone marrow cells with a specific gene deletion to induce a novel immune response.

First phase i clinical trial of CRISPR-edited cells for cancer shows cells safe and durable
Following the first US test of CRISPR gene editing in patients with advanced cancer, researchers report these patients experienced no negative side effects and that the engineered T cells persisted in their bodies -- for months.

Zika virus' key into brain cells ID'd, leveraged to block infection and kill cancer cells
Two different UC San Diego research teams identified the same molecule -- αvβ5 integrin -- as Zika virus' key to brain cell entry.

Read More: Cancer Cells News and Cancer Cells Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.